Jaguar Health Inc. is at a critical juncture, facing significant financial volatility and strategic challenges in the competitive pharmaceutical market.
Jaguar Health, Inc. has experienced significant market volatility, with its stock price fluctuating from a 52-week high of $442.50 to a 52-week low of $4.02, raising concerns about the company’s financial stability and future prospects.